NSF, a global public health and safety organization in Ann Arbor, has announced its acquisition of Cambium Analytica, an analytical testing and development company in Traverse City that serves the natural food, beverage, and dietary supplement industries.
Terms of the deal were not disclosed.
The dietary supplement and food testing and development businesses are poised for explosive growth, fueled by evolving consumer priorities around health and wellness, the rise of food as medicine, product development and innovation and evolving regulations — all of which are continuously shaping and reshaping the industry that feeds and nourishes the global population, according to NSF.
With the addition of Cambium Analytica, NSF is now positioned to more fully meet the accelerating demands of clients resulting from these macrotrends, providing clients with access to integrated, best-in-class solutions at scale.
This enables companies to grow demand for natural food, beverage, and supplement products while ensuring safety and quality, particularly in those seeking to innovate in these industries.
“By integrating Cambium Analytica’s cutting-edge operations with NSF’s eight decades of leadership in safety and testing, we continue to strengthen our position as the partner of choice for clients across the food and nutrition industries,” says Pedro Sancha, president and CEO of NSF. “Together, we anticipate accelerated growth, expanded capabilities, and the addition of exceptional talent to our team.”
Operating as a part of NSF’s largest division, food and nutrition, led by Sarah Krol, vice president, food and nutrition, the addition of Cambium Analytica’s capabilities to NSF allow the organization to stay ahead of market trends and client needs.
“Cambium Analytica stands out for its unwavering commitment to agility, innovation, and a deep understanding of the specific needs of natural product brands,” says Krol. “These qualities distinguish them in the marketplace and make them an ideal fit for our food and nutrition service portfolio.”
Acquisitions have been a commercial focus for NSF, and the organization is committed to growth, doubling down on global expansion, streamlining operations, and building a groundbreaking innovation machine to stay ahead of market demands.
“This partnership represents the perfect alignment of Cambium Analytica’s innovative, customer-centric approach with NSF’s long-established excellence in public health and safety,” says Alex Adams, CEO of Cambium Analytica.
“Together, we’re positioned to lead the next wave of growth in the rapidly evolving consumer products industry — uniting disruptive agility and deep scientific expertise to create an innovative, new testing and inspection ecosystem.”
The acquisition bridges critical gaps in the natural products market. Cambium’s timely in-process QA and batch release testing, contract research, and product development services will integrate seamlessly with NSF’s audit-focused certification programs, offering clients complete support from concept through market compliance.
At this time, Cambium Analytica will be renamed Cambium Analytica, an NSF company, and its 69 employees will continue to operate out of Traverse City.
NSF has 40,000 clients in 110 countries and is a World Health Organization (WHO) Collaborating Center on Food Safety, Water Quality, and Medical Device Safety.
For more information, visit NSF.
